C4 Therapeutics, Inc.

NasdaqGS:CCCC Stock Report

Mkt Cap: US$387.2m

C4 Therapeutics Company Information

C4 Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: C4 Therapeutics, Inc.
  • Ticker: CCCC
  • Exchange: NasdaqGS
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$387.250m
  • Shares outstanding: 48.96m
  • Website: https://www.c4therapeutics.com

Number of Employees


  • C4 Therapeutics, Inc.
  • 490 Arsenal Way
  • Suite 200
  • Watertown
  • Massachusetts
  • 2472
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CCCCNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDOct 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/02/02 00:00
End of Day Share Price2023/02/01 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.